Avingtrans plc (AVG.L)
Chatteris, GB
Avingtrans plc operates as a global provider of specialized engineered products, integrated systems, and technical services, catering to the energy, healthcare, and infrastructure sectors. The company's operations are structured into three distinct divisions: Energy-EPM, Energy-PSRE, and Medical-MII. Avingtrans demonstrates expertise in the design, production, integration, and maintenance of various robust equipment, including electric motors and pumps, steam turbines, gas compressors, heavy-duty pressure vessels, blast-resistant doors, specialized containers, and modular skidded systems. Furthermore, the company develops and manufactures advanced equipment for the scientific and medical communities. This includes components for diagnostic medical devices, high-specification pressure and vacuum vessels, and composite materials tailored for research institutions. They also supply superconducting magnets and helium-free cryogenic systems, which are essential for applications such as Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR). Founded in 1985, Avingtrans plc maintains its headquarters in Chatteris, United Kingdom.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.03% | +4.62% | +11.48% | +20.35% | +38.78% | +41.67% | +65.85% | +65.85% | +94.29% | +279.89% | +459.81% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Industrial - Machinery: +7.4%+14.5% ★ Q4'25: +19.8% (vs Q4'23)
-
EPS growth Industrial - Machinery: +15.6%+72.7% ★ Q4'25: +27.9% (vs Q4'23)
-
FCF margin FCF growth · Industrial - Machinery: +38.2%+6.3% Q4'25: +7.7% (vs Q4'23)
-
EBIT margin Industrial - Machinery: +10.0%+5.2% Q4'25: +7.0% (vs Q4'23)
-
ROIC Industrial - Machinery: +6.8%+5.6% Q4'25: +13.0% (vs Q4'23)
-
Share dilution Industrial - Machinery: +0.0%+0.9% Q4'25: +1.9% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Industrial - Machinery: -0.65×1.62× Q4'25: 0.73× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
May 2007 actual |
May 2008 actual |
May 2009 actual |
May 2011 actual |
May 2012 actual |
May 2013 actual |
May 2014 actual |
May 2015 actual |
May 2016 actual |
May 2017 actual |
May 2018 actual |
May 2019 actual |
May 2020 actual |
May 2021 actual |
May 2022 actual |
May 2023 actual |
May 2024 actual |
May 2025 actual |
May 2026 2 Rev. Ana. 1 EPS Ana. |
May 2027 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
40.03M
est: 40.30M (-0.7%)
|
41.25M
est: 45.42M (-9.2%)
|
37.56M
est: 41.11M (-8.6%)
|
36.26M
est: 37.20M (-2.5%)
|
43.99M
est: 43.64M (+0.8%)
|
45.28M
est: 47.81M (-5.3%)
|
60.27M
est: 62.27M (-3.2%)
|
22.56M
est: 62.20M (-63.7%)
|
21.18M
est: 21.60M (-2.0%)
|
22.71M
est: 21.20M (+7.1%)
|
78.86M
est: 79.68M (-1.0%)
|
104.04M
est: 104.00M (+0.0%)
|
91.96M
est: 114.00M (-19.3%)
|
98.52M
est: 98.59M (-0.1%)
|
99.08M
est: 101.11M (-2.0%)
|
116.44M
est: 108.85M (+7.0%)
|
136.62M
est: 137.70M (-0.8%)
|
156.41M
est: 161.00M (-2.9%)
|
175.00M
174.98M – 175.02M
+8.7% YoY
|
193.30M
193.22M – 193.38M
+10.5% YoY
|
| EBITDA |
5.06M
est: 3.80M (+33.2%)
|
4.08M
est: 4.16M (-2.0%)
|
4.12M
est: 2.13M (+93.8%)
|
3.31M
est: 1.92M (+71.8%)
|
3.31M
est: 3.14M (+5.2%)
|
3.30M
est: 2.91M (+13.4%)
|
1.88M
est: 12.09M (-84.5%)
|
538.0K
est: 4.54M (-88.2%)
|
1.26M
est: 1.20M (+4.9%)
|
398.0K
est: 2.29M (-82.6%)
|
2.17M
est: 1.06M (+103.7%)
|
8.51M
est: 1.44M (+491.6%)
|
6.95M
est: 12.29M (-43.5%)
|
11.03M
est: 10.63M (+3.7%)
|
12.02M
est: 10.72M (+12.1%)
|
13.20M
est: 11.74M (+12.5%)
|
12.54M
est: 14.85M (-15.5%)
|
15.75M
est: 17.36M (-9.3%)
|
18.87M
18.87M – 18.87M
+8.7% YoY
|
20.84M
20.83M – 20.85M
+10.5% YoY
|
| EBIT |
910.0K
est: 3.14M (-71.0%)
|
2.57M
est: 3.73M (-31.0%)
|
2.42M
est: 2.33M (+4.2%)
|
1.73M
est: 2.10M (-17.7%)
|
237.0K
est: 2.03M (-88.3%)
|
1.56M
est: 1.71M (-8.6%)
|
509.0K
est: 2.03M (-75.0%)
|
-1.04M
est: 2.72M (-138.2%)
|
327.0K
est: -432.8K (+175.6%)
|
-247.0K
est: -251.1K (+1.6%)
|
-4.00M
est: -1.54M (-159.4%)
|
3.66M
est: -5.00M (+173.3%)
|
604.0K
est: 6.84M (-91.2%)
|
6.01M
est: 5.92M (+1.6%)
|
7.34M
est: 5.58M (+31.5%)
|
8.05M
est: 6.38M (+26.2%)
|
6.00M
est: 8.27M (-27.4%)
|
8.13M
est: 9.66M (-15.9%)
|
10.50M
10.50M – 10.51M
+8.7% YoY
|
11.60M
11.60M – 11.61M
+10.5% YoY
|
| Net Income |
159.0K
est: 2.19M (-92.8%)
|
1.15M
est: 1.88M (-39.2%)
|
1.13M
est: 1.04M (+8.4%)
|
1.26M
est: 941.9K (+33.9%)
|
935.0K
est: 1.48M (-36.8%)
|
1.30M
est: 1.03M (+26.3%)
|
2.91M
est: 9.77M (-70.2%)
|
-783.0K
est: 2.95M (-126.5%)
|
420.0K
est: 622.1K (-32.5%)
|
-296.0K
est: 34.44M (-100.9%)
|
-4.49M
est: -978.6K (-358.4%)
|
2.51M
est: -5.84M (+143.0%)
|
1.39M
est: 5.17M (-73.2%)
|
3.99M
est: 1.64M (+143.1%)
|
6.48M
est: 1.87M (+246.5%)
|
5.19M
est: 7.54M (-31.1%)
|
3.66M
est: 5.22M (-29.8%)
|
6.56M
est: 6.36M (+3.2%)
|
10.23M
10.19M – 10.27M
+60.9% YoY
|
12.60M
12.49M – 12.71M
+23.2% YoY
|
| SGA |
5.40M
est: 5.46M (-1.2%)
|
7.25M
est: 7.17M (+1.1%)
|
6.64M
est: 7.44M (-10.8%)
|
7.54M
est: 6.73M (+12.0%)
|
9.44M
est: 10.30M (-8.4%)
|
9.53M
est: 10.38M (-8.2%)
|
13.45M
est: 12.41M (+8.3%)
|
2.98M
est: 13.68M (-78.2%)
|
3.55M
est: 1.06M (+235.7%)
|
4.01M
est: 3.93M (+2.2%)
|
23.90M
est: 14.01M (+70.5%)
|
24.03M
est: 22.58M (+6.4%)
|
24.02M
est: 29.66M (-19.0%)
|
23.85M
est: 29.22M (-18.4%)
|
26.65M
est: 33.30M (-20.0%)
|
30.32M
est: 28.32M (+7.1%)
|
38.41M
est: 35.82M (+7.2%)
|
38.81M
est: 41.88M (-7.3%)
|
45.53M
45.52M – 45.53M
+8.7% YoY
|
50.29M
50.26M – 50.31M
+10.5% YoY
|
| EPS |
0.01
est: 0.13 (-93.0%)
|
0.07
est: 0.07 (-10.4%)
|
0.05
est: 0.07 (-27.2%)
|
0.05
est: 0.04 (+14.6%)
|
0.04
est: 0.07 (-45.4%)
|
0.05
est: 0.05 (-0.7%)
|
0.11
est: 0.13 (-18.5%)
|
-0.03
est: 0.10 (-129.2%)
|
0.02
est: 0.01 (+54.1%)
|
-0.01
est: 0.01 (-247.8%)
|
-0.16
est: 0.04 (-497.9%)
|
0.08
est: 0.13 (-37.7%)
|
0.04
est: 0.15 (-71.4%)
|
0.13
est: 0.20 (-36.5%)
|
0.20
est: 0.22 (-8.6%)
|
0.18
est: 0.22 (-19.6%)
|
0.11
est: 0.16 (-29.0%)
|
0.20
est: 0.19 (+5.9%)
|
0.30
0.30 – 0.31
+60.9% YoY
|
0.37
0.37 – 0.38
+23.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-28 | B | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-27 | B | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-26 | B | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-22 | B | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-21 | B | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-19 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-18 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-15 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-14 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-13 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-12 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-11 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-05 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-01 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 2/5 | 2/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 2/5 | 2/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 2/5 | 2/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 2/5 | 2/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 2/5 | 2/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 2/5 | 2/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 2/5 | 2/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 2/5 | 2/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 2/5 | 2/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 2/5 | 2/5 | 4/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Stephen McQuillan | Chief Executive Officer, MD & Executive Director | 523.0K | male |
| Stephen King BEng. | Chief Financial Officer, Company Secretary & Executive Director | 446.0K | male |
| Austen Adams | COO & Director | — | male |
| Stuart Arthur Gall | Chief Executive Officer of Medical & Industrial Imaging | — | male |
| Willem Baralt | Chairman of Medical & Industrial Imaging | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AVG.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
